Search Course Outline
Showing 25 course outlines from 110 matches
26
PHARMACY 311
: Pharmacy 22023 Semester One (1233)
Optimal drug treatment of respiratory, cardiovascular, renal and hepatic diseases and disorders are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law and ethics, dispensing, medicines information, adherence support, clinical communication, physical assessment and management are further developed. Experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 211-213
27
PHARMACY 311
: Pharmacy 22022 Semester One (1223)
Optimal drug treatment of respiratory, cardiovascular, renal and hepatic diseases and disorders are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law and ethics, dispensing, medicines information, adherence support, clinical communication, physical assessment and management are further developed. Experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 211-213
28
PHARMACY 311
: Pharmacy 22021 Semester One (1213)
Optimal drug treatment of respiratory, cardiovascular, renal and hepatic diseases and disorders are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law and ethics, dispensing, medicines information, adherence support, clinical communication, physical assessment and management are further developed. Experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 211-213
29
PHARMACY 311
: Pharmacy 22020 Semester One (1203)
The optimal drug treatment of cardiovascular, hepatic, renal, and infectious diseases and disorders are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law and ethics, dispensing, medicines information, adherence support, clinical communication, physical assessment and management are further developed. Experiential learning opportunities in industry, residential care, general practice and government agencies are provided.
Prerequisite: PHARMACY 211-213
30
PHARMACY 312
: Pharmacy 32024 Semester Two (1245)
Optimal drug treatment of endocrine, musculoskeletal diseases and women’s/men’s health issues are explored through integrated multidisciplinary systems-based approaches. Clinical pharmacy skills in law, ethics, dispensing, medicines information, clinical communication, management, quality and safety, and research skills are further developed. Further experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 311
31
PHARMACY 312
: Pharmacy 32023 Semester Two (1235)
Optimal drug treatment of endocrine, musculoskeletal diseases and women’s/men’s health issues are explored through integrated multidisciplinary systems-based approaches. Clinical pharmacy skills in law, ethics, dispensing, medicines information, clinical communication, management, quality and safety, and research skills are further developed. Further experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 311
32
PHARMACY 312
: Pharmacy 32022 Semester Two (1225)
Optimal drug treatment of endocrine, musculoskeletal diseases and women’s/men’s health issues are explored through integrated multidisciplinary systems-based approaches. Clinical pharmacy skills in law, ethics, dispensing, medicines information, clinical communication, management, quality and safety, and research skills are further developed. Further experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 311
33
PHARMACY 312
: Pharmacy 32021 Semester Two (1215)
Optimal drug treatment of endocrine, haematological, ENT/dental diseases and disorders and women’s/men’s health issues are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law, ethics, dispensing, primary health care, medicines information, clinical communication, quality and safety are further developed. Experiential learning placements focus on development of pharmacy practice skills in community/hospital pharmacy settings throughout New Zealand.
Prerequisite: PHARMACY 311
34
PHARMACY 312
: Pharmacy 32020 Semester Two (1205)
The optimal drug treatment of endocrine, musculoskeletal, eye, ear, nose and throat, and dental diseases and disorders and women’s and men’s health issues are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law and ethics, dispensing, medicines information, clinical communication, management, quality and safety, and research skills are further developed. Further experiential learning opportunities are provided.
Prerequisite: PHARMACY 311
35
PHARMACY 410A
: Dissertation2022 Semester One (1223)
Students undertake an original research project in the areas of pharmacy practice, clinical pharmacy and pharmaceutical science. They develop an awareness of the purpose, nature and practice of research and an ability to undertake an original research project in a small group under the supervision of an academic member of staff.
Prerequisite: PHARMACY 311, 312
To complete this course students must enrol in PHARMACY 410 A and B, or PHARMACY 410
36
PHARMACY 410A
: Dissertation2021 Semester One (1213)
Students undertake an original research project in the areas of pharmacy practice, clinical pharmacy and pharmaceutical science. They develop an awareness of the purpose, nature and practice of research and an ability to undertake an original research project in a small group under the supervision of an academic member of staff.
Prerequisite: PHARMACY 311, 312
To complete this course students must enrol in PHARMACY 410 A and B, or PHARMACY 410
37
PHARMACY 410A
: Dissertation2020 Semester One (1203)
Students undertake an original research project in the areas of pharmacy practice, clinical pharmacy and pharmaceutical science. They develop an awareness of the purpose, nature and practice of research and an ability to undertake an original research project in a small group under the supervision of an academic member of staff.
Prerequisite: PHARMACY 311, 312
To complete this course students must enrol in PHARMACY 410 A and B, or PHARMACY 410
38
PHARMACY 411
: Pharmacy 42022 Semester One (1223)
Optimal drug treatment of neurological, psychiatric diseases and disorders and cancers are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in dispensing, aseptic compounding, medicines information and interdisciplinary teamwork are further developed. Principles in law, ethics, management, leadership and complex communications are applied. Advanced experiential learning placements are provided across a variety of health organisations and pharmacy sites.
Prerequisite: PHARMACY 311, 312
39
PHARMACY 411
: Pharmacy 42021 Semester One (1213)
Optimal drug treatment of neurological, psychiatric diseases and disorders and cancers are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in dispensing, aseptic compounding, medicines information and interdisciplinary teamwork are further developed. Principles in law, ethics, management, leadership and complex communications are applied. Advanced experiential learning placements are provided across a variety of health organisations and pharmacy sites.
Prerequisite: PHARMACY 311, 312
40
PHARMACY 411
: Pharmacy 42020 Semester One (1203)
The optimal drug treatment of haematological, nutritional and psychiatric diseases and disorders and cancers are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in areas such as as law and ethics, dispensing, aseptic compounding, medicines information, management, and teamwork and leadership are further developed. Advanced experiential learning opportunities in pharmacy sites, including in rural locations, are provided.
Prerequisite: PHARMACY 311, 312
41
PHARMACY 412
: Pharmacy 52022 Semester Two (1225)
Optimal drug treatment of musculoskeletal diseases, children’s/older adults’ health issues and patients with multiple morbidities are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills, formulation selection, dispensing, medicines information and teamwork are further developed. Principles in management, leadership, law, ethics, pharmacoeconomics and health technology are applied. Further advanced, varied experiential learning placements are provided.
Prerequisite: PHARMACY 411
42
PHARMACY 412
: Pharmacy 52021 Semester Two (1215)
Optimal drug treatment of musculoskeletal diseases, children’s/older adults’ health issues and patients with multiple morbidities are explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills, formulation selection, dispensing, medicines information and teamwork are further developed. Principles in management, leadership, law, ethics, pharmacoeconomics and health technology are applied. Further advanced, varied experiential learning placements are provided.
Prerequisite: PHARMACY 411
43
PHARMACY 412
: Pharmacy 52020 Semester Two (1205)
The optimal drug treatment of neurological diseases and disorders, children’s and older persons’ health issues and patients with multiple morbidities is explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law and ethics, dispensing, medicines information, management, teamwork and leadership, pharmacoeconomics and health technology assessment are further developed. Further advanced experiential learning opportunities are provided.
Prerequisite: PHARMACY 411
44
PHARMACY 413A
: Research Inquiry in Pharmacy2024 Semester One (1243)
Research methodologies for health, pharmaceutical sciences and pharmacy practice. Students gain foundations in research methods and ethics, capabilities in synthesising literature, analysing data and presenting research findings. Students work in groups to explore, conduct, and present results of research inquiries in appropriate written and oral formats.
Prerequisite: PHARMACY 312
Restriction: PHARMACY 410 To complete this course students must enrol in PHARMACY 413 A and B
Restriction: PHARMACY 410 To complete this course students must enrol in PHARMACY 413 A and B
45
PHARMACY 413A
: Research Inquiry in Pharmacy2023 Semester One (1233)
Research methodologies for health, pharmaceutical sciences and pharmacy practice. Students gain foundations in research methods and ethics, capabilities in synthesising literature, analysing data and presenting research findings. Students work in groups to explore, conduct, and present results of research inquiries in appropriate written and oral formats.
Prerequisite: PHARMACY 312
Restriction: PHARMACY 410 To complete this course students must enrol in PHARMACY 413 A and B
Restriction: PHARMACY 410 To complete this course students must enrol in PHARMACY 413 A and B
46
PHARMACY 701
: Medicine Optimisation 12024 Semester One (1243)
Evaluation of theoretical frameworks to assess health service design. Optimal drug treatment of cancers, neurological and psychiatric diseases and disorders are explored underpinned by critical appraisal of evidence. Clinical pharmacy skills in law, ethics, dispensing, aseptic compounding, medicines information, teamwork and leadership are consolidated. Advanced experiential learning placement opportunities are undertaken in sites throughout New Zealand and overseas locations.
Prerequisite: PHARMACY 312
Restriction: PHARMACY 411
Restriction: PHARMACY 411
47
PHARMACY 701
: Medicine Optimisation 12023 Semester One (1233)
Evaluation of theoretical frameworks to assess health service design. Optimal drug treatment of cancers, neurological and psychiatric diseases and disorders are explored underpinned by critical appraisal of evidence. Clinical pharmacy skills in law, ethics, dispensing, aseptic compounding, medicines information, teamwork and leadership are consolidated. Advanced experiential learning placement opportunities are undertaken in sites throughout New Zealand and overseas locations.
Prerequisite: PHARMACY 312
Restriction: PHARMACY 411
Restriction: PHARMACY 411
48
PHARMACY 702
: Medicine Optimisation 22024 Semester Two (1245)
Theories and critical appraisal of evidence applied to design health service innovations. Optimal treatment of musculoskeletal diseases, disorders and pain, children’s and older persons’ health issues, patients with multiple morbidities explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law, ethics, dispensing, medicines information, teamwork, leadership, pharmacoeconomics and health technology are further developed. Advanced experiential learning placement opportunities.
Prerequisite: PHARMACY 701
Restriction: PHARMACY 412
Restriction: PHARMACY 412
49
PHARMACY 702
: Medicine Optimisation 22023 Semester Two (1235)
Theories and critical appraisal of evidence applied to design health service innovations. Optimal treatment of musculoskeletal diseases, disorders and pain, children’s and older persons’ health issues, patients with multiple morbidities explored through an integrated multidisciplinary systems-based approach. Clinical pharmacy skills in law, ethics, dispensing, medicines information, teamwork, leadership, pharmacoeconomics and health technology are further developed. Advanced experiential learning placement opportunities.
Prerequisite: PHARMACY 701
Restriction: PHARMACY 412
Restriction: PHARMACY 412
50
PHARMACY 750
: Pharmaceutical Formulation2023 Semester One (1233)
Physiological and physicochemical factors in drug delivery and formulation of pharmaceutical products. Consideration of both traditional (e.g., solutions, semi-solids, solids, aerosols) and novel (e.g., liposomal) drug delivery systems based on the experimental literature.
No pre-requisites or restrictions